Stephen J. Traub

Bio: Stephen J. Traub is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Emergency department & Patient satisfaction. The author has an hindex of 18, co-authored 53 publications receiving 1075 citations. Previous affiliations of Stephen J. Traub include New York University & Harvard University.

Body Packing — The Internal Concealment of Illicit Drugs

Abstract: The transportation of illicit drugs by concealment within the body is now a common practice, and it has implications for clinical care. Body packers may ingest dozens of packets containing life-threatening doses of heroin, cocaine, or amphetamines. These smugglers may then present to physicians for evaluation while in legal custody or because of drug-induced toxic effects or obstruction or perforation of the gastrointestinal tract. This review provides guidance for the recognition and management of this clinical problem, which often also poses ethical and legal challenges for the clinician.

Operations research/management contributions to emergency department patient flow optimization: Review and research prospects

Abstract: In recent years, Operations Research/Management (OR/OM) has had a significant impact on improving the performance of hospital Emergency Departments (EDs). This includes improving a wide range of processes involving patient flow from the initial call to the ED through disposition, discharge home, or admission to the hospital. We review approximately 350 related papers to (i) demonstrate the influence of OR/OM in EDs, and (ii) assist both researchers and practitioners with the OR/OM techniques already available to optimize ED patient flow. In addition, we elaborate on some practical challenges yet to be addressed. By shedding light on some less studied aspects that can have significant impacts on ED operations, we also discuss important possibilities for future OR/OM researchers.

Operations Research/Management Contributions to Emergency Department Patient Flow Optimization: Review and Research Prospects

Abstract: In recent years, Operations Research/Management (OR/OM) has had a significant impact on improving the performance of hospital Emergency Departments (EDs). This includes improving a wide range of processes involving patient flow from the initial call to the ED through disposition, discharge home, or admission to the hospital. We review approximately 350 related papers to (a) demonstrate the influence of OR/OM in EDs, and (b) assist both researchers and practitioners with the OR/OM techniques already available to optimize ED patient flow. In addition, we elaborate on some practical challenges yet to be addressed. By shedding light on some less studied aspects that can have significant impacts on ED operations, we also discuss important possibilities for future OR/OM researchers.

Pediatric Body Packing

Abstract: Background Recent events in the United States have led to increased security at national borders, resulting in an unexpected increase in drug seizures. In response, drug smugglers may begin using children as couriers, including using them as "body packers." Objective To look at the occurrence of body packing, the concealing of contraband within the human body, which is well documented in adults, in the pediatric literature. Patient Reports Two cases of pediatric body packing, in boys aged 16 years and 12 years. Patient 1, a 16-year-old boy, presented with findings consistent with opioid intoxication after arriving in the United States on a transcontinental flight. His mental status improved after he received naloxone hydrochloride, and he subsequently confessed to body packing heroin. He was treated with a naloxone infusion and aggressive gastrointestinal decontamination. He ultimately passed 53 packets of heroin, one of which had ruptured. He recovered uneventfully. Patient 2, a 12-year-old boy, presented to the emergency department with rectal bleeding. He had recently arrived in the United States from Europe, and he confessed to body packing heroin. He was treated with whole-bowel irrigation and activated charcoal, and he subsequently passed 84 packets. He also recovered uneventfully. Conclusions We report the first 2 cases of body packing in the pediatric literature and review the diagnosis and management of this clinical entity. Pediatricians should be aware that body packing, regrettably, is not confined to the adult population.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence

Abstract: Objectives: To provide an evidence-based perspective on the prognostic value of novel markers in localised prostate cancer and to identify the best prognostic model including the three classical markers and investigate whether models incorporating novel markers are better. Data sources: Eight electronic bibliographic databases were searched during March–April 2007. The reference lists of relevant articles were checked and various health services research-related resources consulted via the internet. The search was restricted to publications from 1970 onwards in the English language. Methods: Selected studies were assessed, data extracted using a standard template, and quality assessed using an adaptation of published criteria. Because of the heterogeneity regarding populations, outcomes and study type, meta-analyses were not undertaken and the results are presented in tabulated format with a narrative synthesis of the results. Results: In total 30 papers met the inclusion criteria, of which 28 reported on prognostic novel markers and five on prognostic models. A total of 21 novel markers were identified from the 28 novel marker studies. There was considerable variability in the results reported, the quality of the studies was generally poor and there was a shortage of studies in some categories. The marker with the strongest evidence for its prognostic significance was prostate-specific antigen (PSA) velocity (or doubling time). There was a particularly strong association between PSA velocity and prostate cancer death in both clinical and pathological models. In the clinical model the hazard ratio for death from prostate cancer was 9.8 (95% CI 2.8–34.3, pE